A new tool will allow researchers to identify proteins involved in DNA replication and damage repair, processes that go awry in cancer.
New information about signaling pathways involved in colorectal cancer could aid in assessing prognosis and identifying new therapeutic targets for the disease.
A molecule detectable in urine may be helpful in diagnosing colon cancer.
An inexpensive, low-tech test for cervical cancer may be a good option for screening for the disease among HIV-infected women in developing countries.
Drugs that target “epigenetic” changes may help treat or slow the progression of lung cancer.
A protein involved in repairing DNA damage associated with gastric reflux may play a tumor suppressor role in the esophagus and could represent a target for therapies to combat esophageal cancer.